IC
ZY

Iconiq Capital’s Zymergen Inc. Common Stock ZY Stock Holding History

Iconiq Capital’s Portfolio ZY Stock Details ZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-990,765
Closed -$6.63M – 76
2021
Q4 		$6.63M Hold
990,765
– – 0.04% 33
2021
Q3 		$13M Hold
990,765
– – 0.08% 26
2021
Q2 		$39.6M Buy
+990,765
New +$39.1M 0.26% 15

Other funds holding ZY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
TVPI
True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCI
Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return
TSV
Two Sigma Ventures New York $9.61M AUM 58.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Iconiq Capital's ZY Position: Q1 2022 in Review

Iconiq Capital sold out of Zymergen Inc. Common Stock (ZY) in Q1 2022, closing a stake of 990,765 shares — an estimated $6.63M sold.

Iconiq Capital first reported a position in ZY in Q2 2021 and held it in 3 quarters. The position peaked at $39.6M in Q2 2021. 91 funds tracked by Wall St. Rank hold ZY as of Q1 2022.

  • Iconiq Capital reported no remaining Zymergen Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Iconiq Capital sold 990,765 Zymergen Inc. Common Stock shares in Q1 2022, an estimated $6.63M.
  • Iconiq Capital first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Iconiq Capital's Zymergen Inc. Common Stock position peaked at $39.6M in Q2 2021.
  • 91 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q1 2022.

Based on Iconiq Capital's 13F filing for Q1 2022, filed 16 May 2022.